Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
351
Hum J., Shatzel J.J., Jou J.H., Deloughery T.G. The efficacy and safety of direct oral anticoagulants vs
traditional anticoagulants in cirrhosis // Eur. J. Haematol. 2017.
Vol. 98, N. 4. P. 393-397.
Hung M.-J., Mao C.-T., Hung M.-Y., Chen T.-H. Impact of asthma on the development of coronary
vasospastic angina: a population-based cohort study // Medicine.
2015. Vol. 94, N. 42. P. e1880.
Hunter M.R., Cahoon W.D. Jr., Lowe D.K. et al. Angiotensin-converting enzyme inhibitors for
intermittent claudication associated with peripheral arterial disease //
Ann. Pharmacother. 2013. Vol. 47, N. 11. P. 1552-1557.
Huybrechts K.F., Bateman B.T., Palmsten K. et al. Antidepressant use late in pregnancy and risk of
persistent pulmonary hypertension of the newborn // JAMA. 2015.
Vol. 313, N. 21. P. 2142-2151.
Huybrechts K.F., Hernández-Díaz S., Patorno E. et al. Antipsychotic use in pregnancy and the risk for
congenital malformations // JAMA Psychiatry. 2016. Vol. 73,
N. 9. P. 938-946.
Huybrechts K.F., Palmsten K., Avorn J. et al. Antidepressant use in pregnancy and the risk of cardiac
defects // N. Engl. J. Med. 2014. Vol. 370. P. 2397-2407.
Huynh T., Harty B., Claggett B. et al. Comparison of outcomes in patients with diabetes mellitus treated
with versus without insulin + heart failure with preserved left ventricular ejection fraction (from the
TOPCAT study) // Am. J. Cardiol. 2019. Vol. 4.
P. 611-617.
Hwang D., Park K.W., Lee J.M. et al. Efficacy and safety of dual antiplatelet therapy after coronary
stenting in patients with chronic kidney disease // Am. Heart J. 2018.
Vol. 197. P. 103-112.
Hwang Y.J., Dixon S.N., Reiss J.P. et al. Atypical antipsychotic drugs and the risk for acute kidney injury
and other adverse outcomes in older adults: apopulation-based cohort study // Ann. Intern. Med. 2014.
Vol. 161. P. 242-248.
Iammatteo M., Alvarez Arango S., Ferastraoaru D. et al. Safety and outcomes of oral graded challenges
to amoxicillin without prior skin testing // J. Allergy Clin. Immunol.
Pract. 2019. Vol. 1. P. 236-243.
Iliescu C., Balanescu D., Donisan T. et al. Safety of diagnostic and therapeutic cardiac catheterization in
cancer patients with acute coronary syndrome and chronic thrombocytopenia // Am. J. Cardiol. 2018.
Vol. 9. P. 1465-1470.
Indraratna P, Virk S, Gurram D, et al. Use of colchicine in pregnancy: a systematic review and meta-
analysis. Rheumatology. 2017;2:382-387.
Intagliata N.M., Henry Z.H., Maitland H. et al. Direct oral anticoagulants in cirrhosis patients pose similar
risks of bleeding when compared to traditional anticoagulation // Dig. Dis. Sci. 2016. Vol. 61, N. 6. P.
1721-1727.
Источник KingMed.info
352
Iribarren C., Tolstykh I.V., Miller M.K. et al. Adult asthma and risk of coronary heart disease,
cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts // Am. J.
Epidemiol. 2012. Vol. 176, N. 11. P. 1014-1024.
Ishii H., Kobayashi M., Kurebayashi N. et al. Impact of angiotensin II receptor blocker therapy on
coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable
angina pectoris // Am. J. Cardiol. 2013. Vol. 112, N. 3.
P. 363-368.
Ishida J., McCulloch C., Steinman M. et al. Psychoactive Medications and Adverse Outcomes among
Older Adults Receiving Hemodialysis. Journal of the American
Geriatrics Society. 2019. Vol. 3. P. 449-454.
Izzo R., de Simone G., Chinali M. et al. Insufficient control of blood pressure and
incident diabetes // Diabetes Care. 2009. Vol. 32, N. 5. P. 845-850.
James S., Angiolillo D.J., Cornel J.H. et al. Ticagrelor vs. clopidogrel in patients with acute coronary
syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
// Eur. Heart J. 2010. Vol. 31, N. 24. P. 3006-3016.
James W.P., Caterson I.D., Coutinho W. et al. Effect of sibutramine on cardiovascular outcomes in
overweight and obese subjects // N. Engl. J. Med. 2010. Vol. 363,
N. 10. P. 905-917.
Janda S., Park K., Fitzgerald J.M. et al. Statins in COPD // Chest. 2009. Vol. 136,
N. 3. P. 734-743.
Jasiak N.M., Bostwick J.R. Risk of QT/QTc prolongation among newer non-SSRI
antidepressants // Ann. Pharmacother. 2014. Vol. 48, N. 12. P. 1620-1628.
Jensen H.M., Gron R., Lidegaard O. et al. Maternal depression, antidepressant use in pregnancy and
Apgar scores in infants // Br. J. Psychiatry. 2013. Vol. 202, N. 5. P. 347-351.
Jeon S.H., Jaekal J., Lee S.H. et al. Effects of nortriptyline on QT prolongation: a safety pharmacology
study // Hum. Exp. Toxicol. 2011. Vol. 30, N. 10. P. 1649-1656.
Jiang Y.F., Chen X.Y., Ding T. et al. Comparative efficacy and safety of OADs in management of GDM:
network meta-analysis of randomized controlled trials // J. Clin. Endocrinol. Metab. 2015. Vol. 100, N. 5.
P. 2071-2080.
Jiang Z.G., Feldbrugge L., Tapper E.B. et al. Aspirin use is associated with lower indices of liver fibrosis
among adults in the United States // Aliment. Pharmacol. Ther.
2016. Vol. 43, N. 6. P. 734-743.
Jindai K., Nielson C.M., Vorderstrasse B.A., Quiñones A.R. Multimorbidity and functional limitations
among adults 65 or older, NHANES 2005-2012 // Prev.
Chronic. Dis. 2016. Vol. 13. P. E151.
Источник KingMed.info
353
Johnson L.S.B., Juhlin T., Engström G. et al. Reduced forced expiratory volume is associated with
increased incidence of atrial fibrillation: the Malmö Preventive Project // Europace. 2014. Vol. 16, N. 2.
P. 182-188.
Jørgensen M.E., Hlatky M.A., Kober L. et al. β-Blocker-associated risks in patients with uncomplicated
hypertension undergoing noncardiac surgery // JAMA Intern.
Med. 2015. Vol. 175, N. 12. P. 1923-1931.
Joyce E., Fabre A., Mahon N. et al. Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving
biventricular cardiomyopathy: key diagnostic features and literature review // Eur. Heart. J. Acute.
Cardiovasc. Care. 2013. Vol. 2, N. 1. P. 77-83.
Jun M., Foote C., Lv J. et al. Effects of fibrates on cardiovascular outcomes: a systematic review and
meta-analysis // Lancet. 2010. Vol. 375. P. 1875-1884.
Jun M., James M.T., Manns B.J. et al. The association between kidney function and major bleeding in
older adults with atrial fibrillation starting warfarin treatment: population based observational study //
BMJ. 2015. Vol. 350. Article ID h246.
Jun M., Zhu B., Tonelli M. et al. Effects of fibrates in kidney disease: a systematic review and meta-
analysis // J. Am. Coll. Cardiol. 2012. Vol. 60, N. 20. P. 2061-2071.
Jung H., Yang P., Jang E. et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants
in patients with atrial fibrillation with hypertrophic cardiomyopathy: anationwide cohort study // Chest.
2019. Vol. 2. P. 354-363.
Kadoglou N.P.E., Bracke F., Simmers T., Tsiodras S. et al. Influenza infection and heart failure-vaccination
may change heart failure prognosis? // Heart Fail. Rev. 2017.
Vol. 22, N. 3. P. 329-336.
Kalkman D., Aquino M., Claessen B. et al. Residual inflammatory risk and the impact on clinical
outcomes in patients after percutaneous coronary interventions // Eur. Heart J. 2018. Vol. 46. P. 4101-
4108.
Kamberi L., Citaku H., Hoxha-Kamberi T. Supraventricular tachycardia in pregnancy // Med. Arh. 2010.
Vol. 64, N. 5. P. 305-306.
Kaneko A. Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy // Ther. Adv.
Chronic Dis. 2013. Vol. 4, N. 1. P. 15-21.
Kang E.Y., Chen T., Garg S.J. et al. Association of statin therapy with prevention of vision-threatening
diabetic retinopathy // JAMA Ophthalmol. 2019. Jan 10.
Kantor E.D., Rehm C.D., Haas J.S. et al. Trends in prescription drug use among
adults in the United States from 1999-2012 // JAMA. 2015. Vol. 314, N. 17. P. 1818- 1830.
Karatasakis A., Danek B.A., Karacsonyi J. et al. Effect of PCSK9 inhibitors on clinical outcomes in patients
with hypercholesterolemia: ameta-analysis of 35 randomized controlled trials // J. Am. Heart Assoc.
2019. Vol. 12. Article ID e006910.
Katritsis D.G., Toumpoulis I.K., Giazitzoglou E. et al. Latent arterial hypertension in apparently lone atrial
fibrillation // J. Interv. Card. Electrophysiol. 2005. Vol. 13, N. 3. P. 203-207.
Источник KingMed.info
354
Kaufman E.S., Zimmermann P.A., Wang T. et al. Risk of proarrhythmic events in the atrial fibrillation
follow-up investigation of rhythm management (AFFIRM)
study // J. Am. Coll. Cardiol. 2004. Vol. 6. P. 1328-1333.
Kaul P., Ezekowitz J.A., Armstrong P.W. et al. Incidence of heart failure and mortality after acute
coronary syndromes // Am. Heart J. 2013. Vol. 165, N. 3. P. 379-385.
Kauw F., Takx R.A.P, de Jong H.W.A.M. et al. Clinical and Imaging Predictors of Recurrent Ischemic
Stroke: A Systematic Review and Meta-Analysis // Cerebrovasc.
Dis. 2018. Vol. 45, N. 5-6. P. 279-287.
Kawano Y., Takemoto M., Mito T. et al. Silent myocardial ischemia in asymptomatic patients with type 2
diabetes mellitus without previous histories of cardiovascular
disease // Int. J. Cardiol. 2016. Vol. 216. P. 151-155.
Kefer J., Tzikas A., Freixa X. et al. Impact of chronic kidney disease on left atrial appendage occlusion for
stroke prevention in patients with atrial fibrillation // Int. J.
Cardiol. 2016. Vol. 207. P. 335-340.
Keltai M., Tonelli M., Mann J.F. et al. Renal function and outcomes in acute coronary syndrome: impact
of clopidogrel // Eur. J. Cardiovasc. Prev. Rehabil. 2007.
Vol. 14, N. 2. P. 312-318.
Kessing L., Gerds T., Feldt-Rasmussen B. et al. Use of lithium and anticonvulsants and the rate of
chronic kidney disease: anationwide population-based study // JAMA
Psychiatry. 2015. Vol. 72, N. 12. P. 1182-1191.
Khan S.U., Arshad A., Riaz I.B. et al. Meta-analysis of the safety and efficacy of the oral anticoagulant
agents (apixaban, rivaroxaban, dabigatran) in patients with acute
coronary syndrome // Am. J. Cardiol. 2018. Vol. 121, N. 3. P. 301-307.
Khatib R. et al. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of
nonvalvular atrial fibrillation: a systematic review and metaanalysis of randomized controlled trials //
Int. J. Cardiol. 2013. Vol. 165. P. 17-24.
Kheiri B., Osman M., Abdalla A. et al. Tenecteplase versus alteplase for management of acute ischemic
stroke: a pairwise and network meta-analysis of randomized clinical trials // J. Thromb. Thrombolysis.
2018. Vol. 46, N. 4. P. 440-450.
Khwaja Y.H., Tai J.M. Takotsubo cardiomyopathy with use of salbutamol nebulisa-tion and
aminophylline infusion in a patient with acute asthma exacerbation // BMJ Case Rep. 2016. Oct 28.
Article ID 217364.
Kiernan M.S., Stevens S.R., Tang W.H.W. et al. Determinants of Diuretic Responsiveness and Associated
Outcomes During Acute Heart Failure Hospitalization:
An Analysis From the NHLBI Heart Failure Network // J. Card. Fail. 2018. Vol. 24, N. 7. P. 28-438.
Kim B.J., Cho Y.-J., Hong K.-S. et al. Trajectory groups of 24-hour systolic blood pressure after acute
ischemic stroke and recurrent vascular events // Stroke. 2018.
Источник KingMed.info
355
Vol. 8. P. 1836-1842.
Kim J.Y., Jeong M.H., Moon J.H. et al. Impact of clopidogrel loading dose in patients with chronic kidney
disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial
infarction // Am. J. Cardiol. 2012.
Vol. 110, N. 11. P. 1598-1606.
Kim R.G., Loomba R., Prokop L.J., Singh S. Statin use and risk of cirrhosis and related complications in
patients with chronic liver diseases: a systematic review and meta-analysis // Clin. Gastroenterol.
Hepatol. 2017. Vol. 15, N. 10. P. 1521-1530.e8.
Kim S.C., Neogi T., Kang E.H. et al. Cardiovascular risks of probenecid versus allopurinol in older
patients with gout // J. Am. Coll. Cardiol. 2018. Vol. 71, N. 9.
P. 994-1004.
Kim Y., Lee S.-H. Embolic stroke and after-admission atrial fibrillation // Int. J. Cardiol. 2016. Vol. 222. P.
576-580.
Kim T., Yang P., Yu H. et al. Effect of hypertension duration and blood pressure level on ischaemic
stroke risk in atrial fibrillation: nationwide data covering the entire Korean population // Eur. Heart J.
2019. Vol. 10. P. 809-819.
Kim J., Kim S., Myong J. et al. Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis
//. J. Am. Coll. Cardiology. 2019. Vol. 10. P. 1123-1131.
Kiss D., Veegh W., Schragel D. et al. Bronchial asthma causing symptoms suggestive of angina pectoris
// Eur. Respir. J. 2003. Vol. 21, N. 3. P. 473-477.
Klatte D.C.F., Gasparini A., Xu H. et al. Association between proton pump inhibitor use and risk of
progression of chronic kidney disease // Gastroenterology. 2017.
Vol. 153, N. 3. P. 702-710.
Kleveland O., Kunszt G., Bratlie M. et al. Effect of a single dose of the interleukin-6 receptor antagonist
tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial
infarction // Eur. Heart J. 2016. Vol. 37, N. 30.
P. 2406-2413.
Klingbeil A.U., Schneider M., Martus P. et al. A meta-analysis of the effects of treatment on left
ventricular mass in essential hypertension // Am. J. Med. 2003.
Vol. 115. P. 41-46.
Klinger G., Stahl B., Fusar-Poli P., Merlob P. Antipsychotic drugs and breastfeeding // Pediatr.
Endocrinol. Rev. 2013. Vol. 10, N. 3. P. 308-317.
Knott C., Bell S., Britton A. Alcohol consumption and the risk of type 2 diabetes: asystematic review and
dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies //
Diabetes Care. 2015. Vol. 38. P. 1804-1812.
Koff P.B., Jones R.H., Cashman J.M. et al. Proactive integrated care improves quality of life in patients
with COPD // Eur. Respir. J. 2009. Vol. 33. P. 1031-1038.
Источник KingMed.info
356
Köhler O., Petersen L., Mors O., Gasse C. Inflammation and depression: combined use of selective
serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes // Brain Behav.
2015. Vol. 5, N. 8. Article ID e00338.
Kongkaew C., Noyce P.R., Ashcroft D.M. Hospital admissions associated with adverse drug reactions: a
systematic review of prospective observational studies // Ann.
Pharmacother. 2008. Vol. 42, N. 7. P. 1017-1025.
Kongwatcharapong J., Dilokthornsakul P., Nathisuwan S. et al. Effect of dipeptidyl peptidase-4
inhibitors on heart failure: a meta-analysis of randomized clinical trials //
Int. J. Cardiol. 2016. Vol. 211. P. 88-95.
Konrad T., Lübben G., Franzen C. Pioglitazone lowers blood pressure in hypertensive patients with type
2 diabetes mellitus: an open, multicentre, observational study //
Clin. Drug Investig. 2005. Vol. 25, N. 5. P. 337-340.
Kopecky S.L., Bauer D.C., Gulati M. et al. Lack of evidence linking calcium with or without vitamin D
supplementation to cardiovascular disease in generally healthy adults // Ann. Intern. Med. 2016. Vol.
165. P. 867-868.
Koren G., Sarkar M., Einarson A. Safety of using montelukast during pregnancy //
Can. Fam. Physician. 2010. Vol. 56, N. 9. P. 881-882.
Kosiborod M., Cavender M.A., Fu A.Z. et al. Lower risk of heart failure and death in patients initiated on
sodium-glucose cotransporter-2 inhibitors versus other glucose-
lowering drugs // Circulation. 2017. Vol. 136. P. 249-259.
Kosiuk J., Koutalas E., Doering M. et al. Treatment with novel oral anticoagulants in a real-world cohort
of patients undergoing cardiac rhythm device implantations //
Europace. 2014. Vol. 16. P. 1028-1032.
Koskinas K.C., Fragakis N., Katritsis D. et al. Ranolazine enhances the efficacy of amiodarone for
conversion of recent-onset atrial fibrillation // Europace. 2014. Vol. 16.
P. 973-979.
Kotecha D., Holmes J., Krum H. et al. Efficacy of beta blockers in patients with heart failure plus atrial
fibrillation: an individual-patient data meta-analysis // Lancet. 2014. Vol. 384. P. 2235-2243.
Koulouridis I., Alfayez M., Trikalinos T.A. et al. Dose of erythropoiesis-stimulating agents and adverse
outcomes in CKD: ametaregressionanalysis // Am. J. Kidney Dis.
2013. Vol. 61, N. 1. P. 44-56.
Kowalewski M., Suwalski P., Raffa G.M. et al. Meta-analysis of uninterrupted as compared to interrupted
oral anticoagulation with or without bridging in patients undergoing coronary angiography with or
without percutaneous coronary intervention //
Int. J. Cardiol. 2016. Vol. 223. P. 186-194.
Kowalski H.J., Abelmann W.H. The cardiac output at rest in Laennecs cirrhosis // J. Clin. Invest. 1953.
Vol. 32. P. 1025-1033.
Источник KingMed.info
357
Kpaeyeh J.A. Jr, Divoky L., Hyer J.M. et al. Impact of renal function on survival after cardiac
resynchronization therapy // Am. J. Cardiol. 2017. Vol. 120, N. 2.
P. 262-266.
Kranenburg G., Bartstra J.W., Weijmans M. et al. Bisphosphonates for cardiovascular risk reduction:
systematic review and meta-analysis // Atherosclerosis. 2016. Vol. 52.
P. 106-115.
Krill T., Brown G., Weideman R.A. et al. Patients with cirrhosis who have coronary artery disease treated
with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality // Aliment.
Pharmacol. Ther. 2017. Vol. 46, N. 2. P. 183-192.
Krishnan E. Gout and the risk for incident heart failure and systolic dysfunction // BMJ Open. 2012. Vol.
2, N. 1. Article ID e000282.
Krishnan E. Hyperuricemia and incident heart failure // Circ. Heart Fail. 2009.
Vol. 2, N. 6. P. 556-562.
Krishnaswami A., Goh A.C.H., Go A.S. et al. Effectiveness of percutaneous coronary intervention versus
coronary artery bypass grafting in patients with end-stage renal
disease // Am. J. Cardiol. 2016. Vol. 117, N. 10. P. 1596-1603.
Kristin P., Sonia H., Krista F.H. et al. Use of antidepressants near delivery and risk of postpartum
hemorrhage: cohort study of low income women in the United States //
BMJ. 2013. Vol. 347. Article ID f4877.
Kuliczkowski W., Еsior M., Pres D. et al. Effect of glycemic control on response to antiplatelet therapy in
patients with diabetes mellitus and ST-segment elevation myocar-
dial infarction // Am. J. Cardiol. 2012. Vol. 110, N. 3. P. 331-336.
Kumar S., de Lusignan S., McGovern A. et al. Ischaemic stroke, haemorrhage, and mortality in older
patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population
based study from UK primary care // BMJ. 2018.
Vol. 360. Article ID k342.
Kunadian V., Zaman A., Qiu W. Revascularization among patients with severe left ventricular
dysfunction: a meta-analysis of observational studies // Eur. J. Heart Fail.
2011. Vol. 13, N. 7. P. 773-784.
Kunutsor S.K., Seidu S., Khunti K. Statins and secondary prevention of venous thromboembolism:
pooled analysis of published observational cohort studies // Eur.
Heart J. 2017. Vol. 38, N. 20. P. 1608-1612.
Kurstjens S., de Baaij J.H.F., Bouras H. et al. Determinants of hypomagnesemia in patients with type 2
diabetes mellitus // Eur. J. Endocr. 2017. Vol. 176, N. 1. P. 11-19.
Kurth T., Winter A.C., Eliassen A.H. et al. Migraine and risk of cardiovascular disease in women:
prospective cohort study // BMJ. 2016. Vol. 353. Article ID j2610.
Источник KingMed.info
358
Kusters D.M., Lahsinoui H.H., van de Post J.A. et al. Statin use during pregnancy: a systematic review
and meta-analysis // Expert Rev. Cardiovasc. Ther. 2012. Vol. 10,
N. 3. P. 363-378.
Kwok C.S., Jeevanantham V., Dawn B., Loke Y.K. No consistent evidence of differential cardiovascular
risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis // Int. J. Cardiol. 2013.
Vol. 167, N. 3. P. 965-974.
Kwok C.S., Kontopantelis E., Myint P.K. et al. Stroke following percutaneous coronary intervention: type-
Specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society
2007-12 // Eur. Heart J. 2015. Vol. 36.
P. 1618-1628.
Kwon H.L., Triche E.W., Belanger K., Bracken M.B. The epidemiology of asthma during pregnancy:
prevalence, diagnosis, and symptoms // Immunol. Allergy
Clin. North Am. 2006. Vol. 26, N. 1. P. 29-62.
Kwong J.C., Schwartz K.L., Campitelli M.A. et al. Acute myocardial infarction after laboratory-confirmed
influenza infection // N. Engl. J. Med. 2018. Vol. 378, N. 4.
P. 345-353.
Lamb T.S., Thakrar A., Ghosh M. et al. Comparison of two oscillometric blood pressure monitors in
subjects with atrial fibrillation // Clin. Invest. Med. 2010. Vol. 33,
N. 1. P. E54-E62.
Lamberts M., Gislason G.H., Lip G.Y.H. et al. Antiplatelet therapy for stable coronary artery disease in
atrial fibrillation patients taking an oral anticoagulant: anation-wide cohort study // Circulation. 2014.
Vol. 129. P. 1577-1585.
Lapi F., Azoulay L., Yin H. et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors,
and angiotensin receptor blockers with NSAIDs and risk of acute kidney injury: nested case-control
study // BMJ. 2013. Vol. 346. Article ID e8525.
Laporte S., Chapelle C., Caillet P. et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI)
antidepressants: a meta-analysis of observational studies //
Pharmacol. Res. 2017. Vol. 118. P. 19-32.
Larsen T.B., Rasmussen L.H., Gorst-Rasmussen A. et al. Myocardial ischemic events in «real world»
patients with atrial fibrillation treated with dabigatran or warfarin // Am. J. Med. 2014. Vol. 127, N. 4. P.
329-336.e4.
Lauffenburger J.C., Farley J.F., Gehi A.K. et al. Effectiveness and safety of dabigatran and warfarin in real-
world US patients with non-valvular atrial fibrillation: a retrospective cohort study // J. Am. Heart Assoc.
2015. Vol. 4, N. 4. Article ID e001798.
Laurence F., Irene P., Irwin N. Risk of cardiovascular events in people prescribed glucocorticoids with
iatrogenic Cushing's syndrome: cohort study // BMJ. 2012.
Vol. 345. Article ID e4928.
Источник KingMed.info
359
Lawson C., Testani J., Mamas M. et al. Chronic kidney disease, worsening renal function and outcomes
in a heart failure community setting: a UK national study // Int.
J. Cardiol. 2018. Vol. 267. P. 120-127.
Lazarus B., Chen Y., Wilson F.P. et al. Proton pump inhibitor use and the risk of chronic kidney disease
// JAMA Intern. Med. 2016. Vol. 176, N. 2. P. 238-246.
Lee C., Gerds T., Carlson N. et al. Risk of myocardial infarction in anticoagulated patients with atrial
fibrillation // J. Am. Coll. Cardiol. 2018. Vol. 1. P. 17-26.
Lee C.-H., Choi S., Jang E.J. et al. Inhaled bronchodilators and the risk of tachyar-
rhythmias // Int. J. Cardiol. 2015. Vol. 190. P. 133-139.
Lee M., Saver J.L., Liao H.-W. et al. Pioglitazone for secondary stroke prevention // Stroke. 2017. Vol. 2.
P. 388-393.
Lee S. et al. Clinical implication of an impaired fasting glucose and prehypertension related to new
onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort
study in Korea // Eur. Heart J. 2017. Vol. 38, N. 34.
P. 2599-2607.
Lee S.A., Cho S.J., Jeong M.H. et al. Hypoglycemia at admission in patients with acute myocardial
infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in
well-controlled patients // Diabetes Care. 2014. Vol. 37. P. 2366-2373.
Lee S.-J., Uhm J.-S., Kim J.Y. et al. The safety and efficacy of vitamin K antagonist in patients with atrial
fibrillation and liver cirrhosis // Int. J. Cardiol. 2015. Vol. 180.
P. 185-191.
Lee Y.-C., Chang C.-H., Dong Y.-H. et al. Comparing the risks of hospitalized heart failure associated
with glinide, sulfonylurea, and acarbose use in type 2 diabetes: a nationwide study // Int. J. Cardiol.
2017. Vol. 228. P. 1007-1014.
Lei W.Y., Wang J.H., Wen S.H. et al. Risk of acute myocardial infarction in patients with
gastroesophageal reflux disease: A nationwide population-based study // PLoS
One. 2017. Vol. 12, N. 3. e0173899.
Leithead J.A., Rajoriya N., Tehami N. et al. Non-selective β-blockers are associated with improved
survival in patients with ascites listed for liver transplantation // Gut.
2015. Vol. 64. P. 1111-1119.
Lewis J.H., Mortensen M.E., Zweig S. et al. Efficacy and safety of high-dose pravastatin in
hypercholesterolemic patients with well-compensated chronic liver disease // Hepatology. 2007. Vol.
46, N. 5. P. 1453-1463.
Lexis C.H., van der Horst I.C., Lipsic E. et al. Effect of metformin on left ventricular function after acute
myocardial infarction in patients without diabetes: the GIPS-III
randomized clinical trial // JAMA. 2014. Vol. 311, N. 15. P. 1526-1535.
Источник KingMed.info
360
Li D., Wang T., Shen S. et al. Urinary tract and genital infections in patients with type 2 diabetes treated
with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized // Diabetes Obes.
Metab. 2017. Vol. 19, N. 3. P. 348-355.
Li D.Q., Kim R., McArthur E. et al. Risk of adverse events among older adults following co-prescription
of clarithromycin and statins not metabolized by cytochrome P450 3A4 // CMAJ. 2015. Vol. 187, N. 3. P.
174-180.
Li L., Li S., Deng K. et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes:
systematic review and meta-analysis of randomised and observational studies // BMJ. 2016. Vol. 352.
Article ID i610.
Li L., Shen J., Bala M.M. et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes
mellitus: systematic review and meta-analysis of randomised and non-randomised studies // BMJ.
2014. Vol. 348. Article ID g2366.
Li N.C., Lee A., Whitmer R.A. et al. Use of angiotensin receptor blockers and risk of dementia in a
predominantly male population: prospective cohort analysis // BMJ. 2010. Vol. 340. Article ID b5465.
Liang H.L., Ma S.J., Xiao Y.N. et al. Comparative efficacy and safety of oral antidi-abetic drugs and
insulin in treating gestational diabetes mellitus: an updated PRISMA-compliant network // Medicine
(Baltimore). 2017. Vol. 96, N. 38. Article ID e7939.
Liang C.M., Chiu C.H., Wang H.M. et al. First-Line Helicobacter pylori Eradication in Patients with
Chronic Kidney Diseases in Taiwan // Biomed. Res. Int.
2017. 3762194.
Lim A., Stewart K., Konig K., George J. Systematic review of the safety of regular preventive asthma
medications during pregnancy // Ann. Pharmacother. 2011. Vol. 45,
N. 7-8. P. 931-945.
Lim R.G., Cobell W.J., Theivanayagam S. et al. Endoscopy after acute myocardial infarction: an
evaluation of safety // South. Med. J. 2013. Vol. 106, N. 10. P. 545-549.
Lin S.-T., Chen C.-C., Tsang H.-Y. et al. Association between antipsychotic use and risk of acute
myocardial infarction: anationwide case-crossover study // Circulation. 2014. Vol. 130. P. 235-243.
Lin T.K., Chou P., Lin C.H., Hung Y.J. et al. Long-term effect of statins on the risk of new-onset
osteoporosis: A nationwide population-based cohort study // PLoS One. 2018. Vol. 13, N. 5. Article ID
e0196713.
Lin T.-T., Yang Y.-H., Liao M.-T. et al. Primary prevention of atrial fibrillation with angiotensin-converting
enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease
undergoing dialysis // Kidney Int. 2015. Vol. 88.
P. 378-385.
Link M.S., Luttmann-Gibson H., Schwartz J. et al. Acute exposure to air pollution triggers atrial
fibrillation // J. Am. Coll. Cardiol. 2013. Vol. 62, N. 9. P. 816-825.
Liu C.-P. et al. Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of
aspirin-related peptic ulcers // Am. J. Gastroenterol. 2012. Vol. 107.
P. 1022-1029.
Соседние файлы в папке Библиотека им академика М.И. Перельмана